Jules A. Maltz - Mar 14, 2023 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Director
Signature
/s/ Tracy Hogan, Attorney-In-Fact for Jules A. Maltz
Stock symbol
HIMS
Transactions as of
Mar 14, 2023
Transactions value $
$0
Form type
4
Date filed
3/16/2023, 04:52 PM
Previous filing
Mar 6, 2023
Next filing
Mar 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Other -2.45K -11.74% 18.4K Mar 14, 2023 Direct F1
transaction HIMS Class A Common Stock Other +1.22K 1.22K Mar 14, 2023 By Institutional Venture Management XV, LLC F1, F2
transaction HIMS Class A Common Stock Other +1.23K 1.23K Mar 14, 2023 By Institutional Venture Management XVI, LLC F1, F2
holding HIMS Class A Common Stock 220K Mar 14, 2023 By Jules Maltz and Kelly Greenwood Fam Tr UA 07/31/2018
holding HIMS Class A Common Stock 40.7K Mar 14, 2023 By Institutional Venture Partners XV Executive Fund, L.P. F2
holding HIMS Class A Common Stock 7.67M Mar 14, 2023 By Institutional Venture Partners XV, L.P. F2
holding HIMS Class A Common Stock 7.71M Mar 14, 2023 By Institutional Venture Partners XVI, L.P. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the transfer of shares received by the Reporting Person upon the settlement of restricted stock units ("RSUs") that the Reporting Person received pursuant to the Issuer's non-employee director compensation policy. Pursuant to a series of Director Compensation Assignment Agreements, the Reporting Person has agreed to assign the beneficial interest in any equity awards granted to him for his service as director of the Issuer to Institutional Venture Management XV, LLC ("IVM XV") and Institutional Venture Management XVI, LLC ("IVM XVI").
F2 Mr. Maltz is a managing director of IVM XV, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and IVM XVI, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVM XV, IVM XVI, IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.